Sarcoma Clinical Trials in Jefferson City, MO
As of June 2026, 1 paid clinical trial is recruiting for Sarcoma in Jefferson City, Missouri. Recruiting Sarcoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Jefferson City
Filter results
1 clinical trial for Sarcoma
·Clear filters·↓ Download CSVAbout research studies in Jefferson City
Jefferson City has approximately 53 recruiting research studies across a wide range of therapeutic areas. Missouri hosts Washington University School of Medicine in St. Louis and University of Kansas Medical Center's Missouri partners, known for oncology, genomics, and rare-disease research.
Top Research Study Locations in Jefferson City
Researchers run research studies in Jefferson City, MO at 15 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MU Health Care Goldschmidt Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Malignant Solid Neoplasm | 33 |
| Capital Region Southwest Campus | Metastatic Malignant Neoplasm in the Brain, Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8 | 5 |
| Jefferson City Medical Group | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 2 |
| GSK Investigational Site | Chickenpox | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| JCMG - Jefferson City Medical Group | Hallux Valgus, Metatarsus Adductus | 1 |
| Jefferson City Medical Center | T2DM, Type 2 Diabetes Mellitus | 1 |
| Jefferson City Medical Group - 1145 | Non Small Cell Lung Cancer | 1 |
| Jefferson City Medical Group /ID# 257099 | Hypothyroidism | 1 |
| Kailera Clinical Site | Obesity, Overweight | 1 |
| Office of Dental Health, Department of Health and Senior Services | Diabetes, Gingivitis, Oral Infections | 1 |
| Research Site 2 | Hypertriglyceridemia | 1 |
| SSM Health St. Mary's Hospital - Jefferson City | Lumbar Spinal Stenosis | 1 |
| Site Number - 1033 | Graves' Disease | 1 |
| Site Number - 1511 | Graves' Disease | 1 |
Active & Upcoming Studies in Jefferson City (2026)
Recruiting trials in Jefferson City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (33 active studies)
- Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors · NRG Oncology
- Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · Phase 2, Phase 3 · National Cancer Institute (NCI)
Diabetes & metabolic (5 active studies)
- Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus · Phase 2 · Hanmi Pharmaceutical Company Limited
- Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity · Phase 2 · Kailera
Cardiovascular (1 active study)
Common conditions studied in Jefferson City
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Breast Cancer (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Malignant Solid Neoplasm (3 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage III Breast Cancer AJCC v8 (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Chronic Lymphocytic Leukemia (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Jefferson City
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- ECOG-ACRIN Cancer Research Group
- Alliance for Clinical Trials in Oncology
- NRG Oncology
Local regulations and guidelines
Clinical trials in Missouri are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Missouri research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Jefferson City. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Jefferson City
Hipa.ai aggregates every recruiting study in Jefferson City from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Jefferson City?
There are approximately 53 recruiting clinical trials in Jefferson City, Missouri listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Jefferson City pay participants?
Most recruiting trials in Jefferson City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Jefferson City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Jefferson City?
The most common conditions under active study in Jefferson City include Anatomic Stage II Breast Cancer AJCC v8 (3), Breast Cancer (3), Malignant Solid Neoplasm (3), Anatomic Stage I Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Jefferson City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Jefferson City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Jefferson City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Jefferson City?
Recruiting research sites in Jefferson City include MU Health Care Goldschmidt Cancer Center, Capital Region Southwest Campus, Jefferson City Medical Group, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Jefferson City right now?
The largest active categories in Jefferson City are Cancer & tumors (33), Diabetes & metabolic (5), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.